Amgen

AMGN · NASDAQ · USD

$403.04−1.04%−$4.23

Close · October 2, 2026

At a glance

Revenue growth: +9.95%; 2025 vs 2024
Net income growth: +88.53%; 2025 vs 2024
Net margin: 21.0%; 2024: 12.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	90,586	91,839	97,154	65,121	61,165	62,948	59,707	66,416	79,954	77,626
Current assets	29,057	29,030	30,332	22,186	19,385	21,144	18,440	37,618	49,476	46,010
Cash and equivalents	9,129	11,973	10,944	7,629	7,989	6,266	6,037	6,945	3,800	3,241
Short-term investments	—	—	0.0	1,676	48.0	4,381	2,874	22,359	37,878	34,844
Receivables	9,570	6,782	7,942	6,392	5,839	5,324	4,652	4,201	3,237	3,165
Inventory	6,225	6,998	9,518	4,930	4,086	3,893	3,584	2,940	2,834	2,745
Net property, plant and equipment	8,515	7,100	6,592	6,006	5,750	5,297	5,397	4,958	4,989	4,961
Goodwill	18,680	18,637	18,629	15,529	14,890	14,689	14,703	14,699	14,761	14,751
Other intangible assets	22,276	27,699	32,641	16,080	15,182	16,587	19,413	7,443	8,609	10,279
Long-term investments	6,804	4,770	5,057	3,162	4,503	4,076	799	683	1,027	813
Current liabilities	25,489	23,099	18,392	15,687	12,184	11,653	12,835	13,488	9,020	11,204
Accounts payable	2,367	1,908	1,590	1,572	1,366	1,421	1,371	1,207	1,352	917
Long-term debt	50,005	56,549	63,170	37,354	33,222	32,895	26,950	29,510	34,190	30,193
Total debt	55,435	60,879	65,423	39,640	33,979	33,445	30,431	33,929	35,342	30,193
Total liabilities	81,928	85,962	90,922	61,460	54,465	53,539	50,034	53,916	54,713	47,751
Total equity (incl. minority)	8,658	5,877	6,232	3,661	6,700	9,409	9,673	12,500	25,241	29,875
Retained earnings	-25,107	-27,590	-26,549	-28,622	-24,600	-21,408	-21,330	-17,977	-5,072	-438